相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Abdullah Sakkat et al.
RESPIRATORY RESEARCH (2022)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
INTERNATIONAL JOURNAL OF SURGERY (2021)
ERS clinical practice guidelines on treatment of sarcoidosis
Robert P. Baughman et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis
S. Kullberg et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Sarcoidosis as an Autoimmune Disease
Anna A. Starshinova et al.
FRONTIERS IN IMMUNOLOGY (2020)
Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments
Rashi Jain et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Current Medical Therapy for Sarcoidosis
Dominique Valeyre et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Sarcoidosis: an update on current pharmacotherapy options and future directions
Pilar Brito-Zeron et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
Adriane D. M. Vorselaars et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis
Marc A. Judson et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis
Petal A. Wijnen et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Anti-TNF therapeutics for the treatment of sarcoidosis
Heleen A. Crommelin et al.
IMMUNOTHERAPY (2014)
Associations between TNF-alpha-308 A/G and lymphotoxin-alpha+252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis
Gwan Gyu Song et al.
MOLECULAR BIOLOGY REPORTS (2014)
Established and experimental medical therapy of pulmonary sarcoidosis
Robert P. Baughman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis
Robert J. Pariser et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Granuloma formation in pulmonary sarcoidosis
Caroline E. Broos et al.
FRONTIERS IN IMMUNOLOGY (2013)
The clinical and immunologic features of pulmonary fibrosis in sarcoidosis
Karen C. Patterson et al.
TRANSLATIONAL RESEARCH (2012)
The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis
P. A. Wijnen et al.
TISSUE ANTIGENS (2010)
Treatment of sarcoidosis
Robert P. Baughman et al.
CLINICS IN CHEST MEDICINE (2008)
The diagnosis of sarcoidosis
Marc A. Judson
CLINICS IN CHEST MEDICINE (2008)
The immunology of sarcoidosis
Alicia K. Gerke et al.
CLINICS IN CHEST MEDICINE (2008)
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
M. A. Judson et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Effectiveness of infliximab in treating selected patients with sarcoidosis
Samer Saleh et al.
RESPIRATORY MEDICINE (2006)
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
Robert P. Baughman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis
HP Dai et al.
CHEST (2005)
Tumor necrosis factor: An apoptosis JuNKie?
EE Varfolomeev et al.
CELL (2004)
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis
JP Utz et al.
CHEST (2003)
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis
H Fehrenbach et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
AMF Yee et al.
ANNALS OF INTERNAL MEDICINE (2001)